D. Voduc
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Estrogen and related hormone effects, Cancer Treatment and Pharmacology, Breast Lesions and Carcinomas
Most-Cited Works
- → A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer(2010)818 cited
- → External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial(2019)412 cited
- → Breast cancer molecular subtypes and locoregional recurrence(2008)5 cited
- → The responsiveness of intrinsic subtypes to adjuvant anthracyclines versus nonanthracyclines in NCIC.CTG MA.5 randomized trial.(2011)3 cited
- → The other triple-negative breast cancer: Immunohistochemical and clinicopathologic characterization of the Claudin-low subtype.(2011)1 cited
- → EP-1186: Neoadjuvant systemic therapy utilization in breast cancer; potential impact on nodal radiotherapy(2015)
- → Ki-67 is a Luminal B marker that identifies a high-risk subgroup in hormone receptor positive and node negative breast cancer(2007)
- → Abstract P6-07-10: Luminal A vs. Basal-like Breast Cancer: time dependent changes in the risk of relapse in the absence of treatment(2012)
- → AlphaB-crystallin predicts poor breast cancer survival in basal-like tumors(2008)
- → Abstract P4-16-02: A survival benefit from locoregional radiotherapy for node-positive and CMF treated breast cancer is most significant in Luminal A tumors(2012)